Stephen W Webster - Net Worth and Insider Trading
Stephen W Webster Net Worth
The estimated net worth of Stephen W Webster is at least $768,805 dollars as of 2024-11-13. Stephen W Webster is the Director of Viking Therapeutics Inc and owns about 8,000 shares of Viking Therapeutics Inc (VKTX) stock worth over $484,880. Stephen W Webster is the CFO of Spark Therapeutics Inc and owns about 2,500 shares of Spark Therapeutics Inc (ONCE) stock worth over $283,925. Stephen W Webster is also the Director of Nabriva Therapeutics PLC and owns about 458 shares of Nabriva Therapeutics PLC (NBRVF) stock worth over $0. Details can be seen in Stephen W Webster's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen W Webster has not made any transactions after 2022-08-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stephen W Webster
Stephen W Webster Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen W Webster owns 6 companies in total, including Nabriva Therapeutics PLC (NBRVF) , NextCure Inc (NXTC) , and TCR2 Therapeutics Inc (TCRR) among others .
Click here to see the complete history of Stephen W Webster’s form 4 insider trades.
Insider Ownership Summary of Stephen W Webster
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
NBRVF | Nabriva Therapeutics PLC | 2022-08-02 | director |
NXTC | NextCure Inc | 2019-05-08 | director |
TCRR | TCR2 Therapeutics Inc | 2020-12-10 | director |
2018-05-29 | director | ||
2019-12-17 | CHIEF FINANCIAL OFFICER | ||
2021-01-07 | director |
Stephen W Webster Latest Holdings Summary
Stephen W Webster currently owns a total of 3 stocks. Among these stocks, Stephen W Webster owns 8,000 shares of Viking Therapeutics Inc (VKTX) as of May 29, 2018, with a value of $484,880 and a weighting of 63.07%. Stephen W Webster owns 2,500 shares of Spark Therapeutics Inc (ONCE) as of November 16, 2017, with a value of $283,925 and a weighting of 36.93%. Stephen W Webster also owns 458 shares of Nabriva Therapeutics PLC (NBRVF) as of August 2, 2022, with a value of $0 and a weighting of 0%.
Latest Holdings of Stephen W Webster
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
VKTX | Viking Therapeutics Inc | 2018-05-29 | 8,000 | 60.61 | 484,880 |
ONCE | Spark Therapeutics Inc | 2017-11-16 | 2,500 | 113.57 | 283,925 |
NBRVF | Nabriva Therapeutics PLC | 2022-08-02 | 458 | 0.00 | 0 |
Holding Weightings of Stephen W Webster
Stephen W Webster Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen W Webster has made a total of 0 transactions in Viking Therapeutics Inc (VKTX) over the past 5 years. The most-recent trade in Viking Therapeutics Inc is the acquisition of 8,000 shares on May 29, 2018, which cost Stephen W Webster around $41,680.
According to the SEC Form 4 filings, Stephen W Webster has made a total of 0 transactions in Spark Therapeutics Inc (ONCE) over the past 5 years. The most-recent trade in Spark Therapeutics Inc is the sale of 10,000 shares on November 16, 2017, which brought Stephen W Webster around $701,400.
According to the SEC Form 4 filings, Stephen W Webster has made a total of 2 transactions in Nabriva Therapeutics PLC (NBRVF) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Nabriva Therapeutics PLC is the sale of 313 shares on August 2, 2022, which brought Stephen W Webster around $1,487.
Insider Trading History of Stephen W Webster
- 1
Stephen W Webster Trading Performance
GuruFocus tracks the stock performance after each of Stephen W Webster's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen W Webster is 45.02%. GuruFocus also compares Stephen W Webster's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen W Webster within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen W Webster's insider trading performs compared to the benchmark.
Performance of Stephen W Webster
Stephen W Webster Ownership Network
Ownership Network List of Stephen W Webster
Ownership Network Relation of Stephen W Webster
Stephen W Webster Owned Company Details
What does Nabriva Therapeutics PLC do?
Who are the key executives at Nabriva Therapeutics PLC?
Stephen W Webster is the director of Nabriva Therapeutics PLC. Other key executives at Nabriva Therapeutics PLC include Chief Executive Officer Hogan H Michael Iii , Chief Financial Officer David Maggio , and Chief Executive Officer Broom Colin Md .
Nabriva Therapeutics PLC (NBRVF) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Nabriva Therapeutics PLC (NBRVF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nabriva Therapeutics PLC (NBRVF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Nabriva Therapeutics PLC (NBRVF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nabriva Therapeutics PLC Insider Transactions
Stephen W Webster Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen W Webster. You might contact Stephen W Webster via mailing address: C/o Optimer Pharmaceuticals, Inc, 101 Hudson Street, San Diego Ca 07302.